Advanced Biomed (ADVB) Net Income towards Common Stockholders (2023 - 2025)

Advanced Biomed has disclosed Net Income towards Common Stockholders across 3 years of filings, most recently posting -$144257.0 for Q4 2025.

• Net Income towards Common Stockholders for Q4 2025 came in at -$144257.0, up 56.07% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 27.57% YoY), and the FY2025 annual result was -$3.3 million, down 17.13% from the prior year.
• Net Income towards Common Stockholders came in at -$144257.0 for Q4 2025 at Advanced Biomed, up from -$386901.0 in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$144257.0 in Q4 2025 to a low of -$1.5 million in Q2 2025.
• The 3-year median for Net Income towards Common Stockholders is -$328410.0 (2024), against an average of -$535483.1.
• Across the five-year window, Net Income towards Common Stockholders tumbled 125.95% in 2024 and jumped 82.35% in 2025, its largest moves.
• Advanced Biomed's Net Income towards Common Stockholders stood at -$145345.0 in 2023, then sank by 125.95% to -$328410.0 in 2024, then jumped by 56.07% to -$144257.0 in 2025.
• The last three Net Income towards Common Stockholders figures came in at -$144257.0 (Q4 2025), -$386901.0 (Q3 2025), and -$1.5 million (Q2 2025), per Business Quant data.